Mind Medicine Inc, a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced the appointment of Javier A. Muniz, M.D.,...
Mind Medicine Inc., a leading biotech company developing psychedelic-inspired therapies, announced the initiation of Phase 2a proof-of-concept (POC) trial of lysergic acid diethylamide (LSD)...